Celldex Therapeutics reported $14.18M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 14842M 257M
Applied Genetic Technologies AGTC:US $ 21.71M 2M
Aptinyx Inc APTX:US $ 6.28M 2.9M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Biocept BIOC:US $ 10.4M 0.75M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Celldex Therapeutics CLDX:US $ 14.18M 0.31M
Cytrx CYTR:US 2.79M 301.42K
Glaxosmithkline GSK:US $ 22417M 1030M
Immunogen IMGN:US $ 111.78M 8.53M
Merrimack Pharmaceuticals MACK:US $ 770K 1.45M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Newlink Genetics NLNK:US $ 6.05M 0.72M
Northwest Biotherapeutics NWBO:US 312.32M 48.39M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
Seattle Genetics SGEN:US $ 698.43M 264.6M